JONATHAN MARTINEZ: Open Payments
NPI 1750491908 · MONTCLAIR, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$782 in 31 payments from 13 companies in 2025. Trend: 2023 $940 · 2024 $985 · 2025 $782
Food & beverage: $782
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 8 | $275 |
| Lilly USA, LLC | 5 | $121 |
| Phathom Pharmaceuticals, Inc. | 6 | $103 |
| Esperion Therapeutics, Inc. | 1 | $68 |
| ABBVIE INC. | 2 | $36 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $35 |
| SHIELD THERAPEUTICS INC | 1 | $32 |
| Astellas Pharma US Inc | 1 | $27 |
| Otsuka America Pharmaceutical, Inc. | 1 | $22 |
| Aimmune Therapeutics, Inc. | 1 | $19 |
Products named: AIRSUPRA, VOQUEZNA, JARDIANCE, NEXLETOL, MOUNJARO, LINZESS, Kerendia, ACCRUFER.
Industry payments across CA — which companies pay providers there.
